» Articles » PMID: 37236807

MRI Features and Their Association With Outcomes in Children With Anti-NMDA Receptor Encephalitis

Abstract

Objectives: How brain MRI lesions associate with outcomes in pediatric anti-NMDA receptor encephalitis (pNMDARE) is unknown. In this study, we correlate T2-hyperintense MRI brain lesions with clinical outcomes in pNMDARE.

Methods: This was a multicenter retrospective cohort study from 11 institutions. Children younger than 18 years with pNMDARE were included. One-year outcomes were assessed by the modified Rankin Score (mRS) with good (mRS ≤2) and poor (mRS ≥3) outcomes.

Results: A total of 175 pNMDARE subjects were included, with 1-year mRS available in 142/175 (81%) and 60/175 (34%) had abnormal brain MRIs. The most common T2-hyperintense lesion locations were frontal, temporal, and parietal. MRI features that predicted poor 1-year outcomes included abnormal MRI, particularly T2 lesions in the frontal and occipital lobes. After adjusting for treatment within 4 weeks of onset, improvement within 4 weeks, and intensive care unit admission, MRI features were no longer associated with poor outcomes, but after multiple imputation for missing data, T2 frontal and occipital lesions associated with poor outcomes.

Discussion: Abnormal frontal and occipital lesions on MRI may associate with 1-year mRS in pNMDARE. MRI of the brain may be a helpful prognostication tool that should be examined in future studies.

Citing Articles

Pediatric Neuroimaging of Multiple Sclerosis and Neuroinflammatory Diseases.

Dunseath C, Bova E, Wilson E, Care M, Cecil K Tomography. 2024; 10(12):2100-2127.

PMID: 39728911 PMC: 11679236. DOI: 10.3390/tomography10120149.


Rate of Autoimmune Encephalitis in Children With First-Episode Psychosis.

Treiman G, Blackwell L, Howarth R, Gombolay G Pediatr Neurol. 2024; 161:113-116.

PMID: 39368246 PMC: 11602345. DOI: 10.1016/j.pediatrneurol.2024.09.011.


Isolated Psychiatric Symptoms in Children With Anti-N-Methyl-d Aspartate Receptor Encephalitis.

Gombolay G, Brenton J, Yang J, Stredny C, Kammeyer R, Fisher K Pediatr Neurol. 2024; 159:12-15.

PMID: 39094249 PMC: 11381152. DOI: 10.1016/j.pediatrneurol.2024.07.009.


Electroconvulsive therapy in N-methyl-d-aspartate receptor encephalitis: A retrospective cohort and scoping review of literature.

Wright M, Guasp M, Lachner C, Day G, Gombolay G, Titulaer M J Neuroimmunol. 2024; 392:578369.

PMID: 38823118 PMC: 11539951. DOI: 10.1016/j.jneuroim.2024.578369.


Contribution of cerebrospinal fluid antibody titers and sex to acute cerebral blood flow in patients with anti-NMDAR autoimmune encephalitis.

Miao A, Wang K Front Immunol. 2024; 15:1299898.

PMID: 38495877 PMC: 10940436. DOI: 10.3389/fimmu.2024.1299898.

References
1.
Nosadini M, Eyre M, Molteni E, Thomas T, Irani S, Dalmau J . Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis. JAMA Neurol. 2021; 78(11):1333-1344. PMC: 8453367. DOI: 10.1001/jamaneurol.2021.3188. View

2.
Kashyap N, Morris M, Loerinc L, Benoit M, Blackwell L, Howarth R . The neutrophil-to-lymphocyte ratio is associated with intubation in pediatric anti-NMDA receptor encephalitis: A retrospective study. J Neuroimmunol. 2022; 370:577931. PMC: 9675910. DOI: 10.1016/j.jneuroim.2022.577931. View

3.
Nosadini M, Thomas T, Eyre M, Anlar B, Armangue T, Benseler S . International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis. Neurol Neuroimmunol Neuroinflamm. 2021; 8(5). PMC: 8299516. DOI: 10.1212/NXI.0000000000001052. View

4.
Balu R, McCracken L, Lancaster E, Graus F, Dalmau J, Titulaer M . A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis. Neurology. 2018; 92(3):e244-e252. PMC: 6340387. DOI: 10.1212/WNL.0000000000006783. View

5.
Zhang T, Duan Y, Ye J, Xu W, Shu N, Wang C . Brain MRI Characteristics of Patients with Anti--Methyl-D-Aspartate Receptor Encephalitis and Their Associations with 2-Year Clinical Outcome. AJNR Am J Neuroradiol. 2018; 39(5):824-829. PMC: 7410660. DOI: 10.3174/ajnr.A5593. View